Article
Inorganic Chemistry, Vol. 48, No. 23, 2009 11179
8.20 (2H, s, NdCH), 7.42-7.40 (2H, m, H5), 7.28-7.26 (2H, m, H3),
7.18-7.10 (4H, m, aryl o-H), 7.03-7.01 (2H, m, H4), 6.87-6.285
(6H, m, aryl m- and p-H); NMR [δH (300 MHz, C6D6)]: δ 154.1
(N=CH), 147.0 (aryl ipso-C), 138.6 (C5), 138.1 (C2), 129.6 (aryl m-
C), 125.6 (aryl p-C), 121.6 (C3), 120.5 (aryl o-C), 115.6 (C4). ESI-
MS: m/z 403 [MþH]þ (calcd. for C22H19N4Zn [MþH]þ, 403).
Synthesis of Bis(pyrrole-1-ylmethylene-(2,6-diisopropylphe-
nyl)amine)zinc (1b). This compound was already reported in
the literature, although synthesized by a different method.19 The
same procedure described for 1a was followed, using a solution
of sodium salt IIIb prepared in situ (0.25 g, 1.0 mmol), to give
0.13 g (44%) of a pale yellow powder.
Anal. found (calculated) (C34H42N4Zn): C 71.29 (71.38), H
7.49 (7.40), N 9.96 (9.79)%. NMR [δH (300 MHz, C6D6)]: δ 7.49
(2H, s, NdCH), 7.12 (2H, br s, H5), 6.98-6.92 (6H, m, aryl m-
and p-H), 6.84 (2H, dd, J1=3.6 Hz, J2=1.2 Hz, H3), 6.55 (2H,
dd, J1 = 3.6 Hz, J2 = 1.5 Hz, H4), 3.13 (4H, h, J = 6.6 Hz,
CH(CH3)2), 1.06 (12H, d, J=6.6 Hz, CH(CH3)2), 0.60 (12H, d,
J=6.6 Hz, CH(CH3)2). NMR [δC (75 MHz, C6D6)]: δ 161.3
(N=CH), 144.9 (aryl ipso-C), 141.9 (aryl o-C), 137.6 (C2), 136.6
(aryl p-C), 126.2 (C5), 124.0 (aryl m-C), 120.7 (C3), 115.1 (C4),
28.4 (CH(CH3)2), 24.6 (CH(CH3)2), 23.0 (CH(CH3)2). ESI-MS:
m/z 571 [MþH]þ (calcd. for C34H43N4Zn [MþH]þ, 571).
Synthesis of Bis(phenanthro[9,10-c]pyrrole-1-ylmethylene-phe-
nylamine)zinc (2a). Procedure A. The same procedure de-
scribed for 1a was followed, but a solution of sodium salt IVa
prepared in situ (0.16 g, 0.5 mmol) was employed. Extraction of
the reaction products with toluene, until extracts remained
colorless, and removal of the solvent by vacuum evaporation,
afforded a yellow-mustard powder, which was recrystallized in
CH2Cl2 and double-layered with n-hexane, at -20 ꢀC, giving
0.88 g (50%) of a bright green powder.
Table 1. Crystal Data and Structure Refinement for Compounds IIb and 2b
IIb
2b
formula
M
λ/ A
T/ K
C
29H28N2
C58H54N4Zn
872.42
0.71073
150
404.53
0.71073
150
˚
crystal system
space group
monoclinic
P21/c
12.6922 (12)
20.6575 (21)
8.8788 (9)
90
108.119 (6)
90
2212.5 (4)
4
1.214
monoclinic
Cc
16.105(8)
12.486(7)
24.603(13)
90
108.52(3)
90
4691(4)
4
1.235
˚
a/ A
˚
b/ A
˚
c/ A
R/ deg
β/ deg
γ/ deg
3
˚
V/ A
Z
F
calc/ g cm-3
μ/ mm-1
max/ deg
0.071
25.74
0.566
25.03
θ
total data
unique data
Rint
R [I > 3σ(I)]
wR
goodness of fit
F min, F max
30099
4179
0.1099
0.0628
0.1484
1.013
37322
7901
0.3488
0.0898
0.1710
0.835
-0.407
0.519
-0.360
0.441
Procedure A. A solution of sodium salt IVb prepared in situ
(0.20 g, 0.5 mmol) was employed. After extraction of the
reaction products with toluene, the resulting solution was con-
centrated and stored at -20 ꢀC, giving 0.15 g (70%) of a bright
yellow powder.
Procedure B. A solution of 1-formiminophenanthro[9,10-c]-
pyrrole IIa (0.32 g, 1.0 mmol) in a mixture of solvents, toluene
(25 mL), and THF (10 mL), was added to a solution of ZnMe2
(0.5 mL of a 2.0 M solution in toluene, 1.0 mmol) diluted with
toluene (20 mL), at -80 ꢀC. After the addition, the mixture was
warmed slowly to room temperature and stirred overnight. All
volatiles were evaporated, and the resulting residue was washed
with n-hexane and extracted with toluene until the extracts were
colorless. The remaining residue was extracted with THF and
filtered. The resulting yellow-greenish solutions were evapo-
rated, and the residue redissolved in toluene, double-layered
with n-hexane, and cooled to -20 ꢀC, to yield 0.34 g (95% based
on IIa) of a yellow-green powder.
Procedure B. A solution of 1-formiminophenanthro[9,10-c]-
pyrrole IIb (0.20 g, 0.5 mmol) in a mixture of solvents, toluene
(10 mL), and THF (5 mL) was added to a solution of ZnMe2
(0.25 mL of a 2.0 M solution in toluene, 0.5 mmol) diluted with
toluene (10 mL), at -80 ꢀC. After the addition, the mixture was
warmed slowly to room temperature and stirred overnight. All
volatiles were evaporated, and the resulting residue was washed
with n-hexane and extracted with toluene. The resulting bright
yellow solution was evaporated, redissolved in toluene, double-
layered with n-hexane and cooled to -20 ꢀC, to yield 0.19 g (89%
based on IIb) of a yellow powder.
Anal. Found (calcd) (C58H54N4Zn): C 79.63 (79.85), H 6.55
(6.24), N 6.13 (6.42). NMR [δH (300 MHz, CD2Cl2)]: δ 8.80 (2H,
s, NdCH), 8.66 (2H, d, J=7.8 Hz, H15 or H12), 8.58 (2H, d, J=
7.8 Hz, H12 or H15), 8.27 (2H, d, J = 8.4 Hz, H18 or H9),
8.21-8.19 (4H, m, H9 or H18 and H16 or H11), 7.58-7.48 (8H,
m, H10, H11 or H16, H17 and aryl p-H), 7.16-7.06 (6H, m, H5
and aryl m-H), 3.23 (4H, br s, CH(CH3)2), 1.20 (12H, d, J=6.6 Hz,
CH(CH3)2), 0.52 (12H, d, J=6.3 Hz, CH(CH3)2); NMR [δH
(300 MHz, C6D6)]: δ 8.85 (2H, s, NdCH), 8.46 (2H, d, J =
8.0 Hz, H15 or H12), 8.43 (2H, d, J=8.5 Hz, H12 or H15), 8.24
(2H, d, J=7.8 Hz, H18 or H9), 8.14 (2H, d, J=7.6 Hz, H9 or
H18), 8.04 (2H, s, H5), 7.44 (2H, t, J=7.1 Hz, H16 or H11),
7.38-7.27 (6H, m, H10, H11 or H16 and H17), 7.05-6.95 (6H,
m, aryl m- and p-H), 3.28 (4H, br s, CH(CH3)2), 1.15 (24H, d, J=
6.8 Hz, CH(CH3)2). NMR [δC (75 MHz, CD2Cl2)]: δ 161.0
(N=CH), 145.0 (aryl ipso-C), 142.4 (aryl o-C), 132.1 (C9 and
C18), 131.2 (C13 or C14), 130.8 (C14 or C13), 129.2 (C8 or C19),
128.6 (C19 or C8), 128.1 (C4 or C3), 127.6 (C17 or C10), 127.4
(C10 or C17), 127.1 (C3 or C4), 127.0 (C2), 126.5 (C16 or C11),
126.3 (C11 or C16), 125.1 (aryl p-C), 124.5 (C15 and C12), 124.4
(aryl m-C), 123.8 (C12 or C15), 123.3 (C5), 28.7 (CH(CH3)2),
24.8 (CH(CH3)2), 23.0 (CH(CH3)2). ESI-MS: m/z 871 [MþH]þ
(calcd. for C58H55N4Zn [MþH]þ, 871).
Anal. Found (calcd) (C46H30N4Zn): C 78.92 (78.46), H 4.02
(4.29), N 8.12 (7.96). NMR [δH (300 MHz, CD2Cl2)]: δ 9.47 (2H, s,
NdCH), 8.68 (2H, d, J=8.1 Hz, H15 or H12), 8.58 (2H, d, J=
8.1 Hz, H18 or H9), 8.53 (2H, d, J=8.4 Hz, H12 or H15), 8.23
(2H, s, H5), 8.15 (2H, d, J=6.6 Hz, H9 or H18), 7.67-7.49 (8H,
m, H10, H11, H16 and H17), 7.33-7.24 (6H, m, aryl m- and
p-H), 7.10-7.08 (4H, m, aryl o-H); NMR [δH (300 MHz, C6D6)]:
δ 9.14 (2H, s, NdCH), 8.54 (2H, dd, J=6.9 Hz, J=2.4 Hz, H15
or H12), 8.47 (2H, dd, J=8.4 Hz, J=1.2 Hz, H18 or H9), 8.36
(2H, dd, J=6.3 Hz, J=2.4 Hz, H12 or H15), 8.08 (2H, dd, J=
7.5 Hz, J=1.5 Hz, H9 or H18), 7.84 (2H, s, H5), 7.48-7.35 (8H,
m, H10, H11, H16 and H17), 6.97-6.88 (6H, m, aryl m- and
p-H), 6.80-6.75 (4H, m, aryl o-H). NMR [δC (75 MHz,
CD2Cl2)]: δ 160.7 (aryl ipso-C), 152.4 (N=CH), 139.2 (aryl o-
C), 133.6 (C14 or C13), 130.8 (C13 or C14), 128.6 (C8 or C19),
128.4 (C19 or C8), 127.8 (C9 or C18), 127.6 (C18 or C9), 126.6
(C16 or C11), 126.2 (C4 or C3), 126.0 (C11 or C16), 125.7 (C17
or C10), 125.0 (C4 or C3), 124.7 (aryl p-C), 124.4 (C10 or C17),
123.9 (C15 or C12), 123.6 (aryl m-C), 123.3 (C12 or C15), 122.7
(C2), 116.2 (C5). ESI-MS: m/z 703 [MþH]þ (calcd. for
C46H31N4Zn [MþH]þ, 703).
Synthesis of Bis(phenanthro[9,10-c]pyrrole-1-ylmethylene-(2,6-
diisopropylphenyl)amine)zinc (2b). The same procedures de-
scribed for 2a were followed.
X-ray Experimental Data. Crystallographic and experimental
details of crystal structure determinations are listed in Table 1.
The crystal of complex 2b was selected under an inert atmosphere,